Therefore, our findings that circulating TSP2 levels were also associated with indices of LV hypertrophy and subsequent development of diastolic dysfunction in patients without pre-existing CVD or HF at baseline provided further clinical support that TSP2 could possibly be implicated in adverse left ventricular remodeling earlier on, even before the development of clinical HF. This evidence concerns the gene THBS2 and hydrops fetalis.